Våtsveen TK, Giliberto M, Bjornsdottir V, Centonze F, Besse A, Frey Y, Skånland SS, Tveita A, Alirezaylavasani A, Imbery JF, Misund K, Reiterer V, Zahoor M, Driessen C, Besse L, Tasken K, Schjesvold FH, Farhan H, Munthe LA(2025) Targeting proteostasis in multiple myeloma through inhibition of LTK Leukemia(in press) DOI 10.1038/s41375-025-02682-8, PubMed 40634511
Subbiah V, Curigliano G, Sicklick JK, Kato S, Tasken K, Medford A, Rieke DT, Chen HZ, Wahida A, Buschhorn L, Horgan D, Kurzrock R(2025) Cancer treatment paradigms in the precision medicine era Nat Med(in press) DOI 10.1038/s41591-025-03711-w, PubMed 40394190
Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS(2025) Protein Profiles Predict Treatment Responses to the PI3K Inhibitor Umbralisib in Patients with Chronic Lymphocytic Leukemia Clin Cancer Res, 31(10), 1943-1955 DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050